17-32266296-A-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_138328.3(RHBDL3):āc.107A>Cā(p.Glu36Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000625 in 1,454,846 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_138328.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RHBDL3 | NM_138328.3 | c.107A>C | p.Glu36Ala | missense_variant | 1/9 | ENST00000269051.9 | NP_612201.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RHBDL3 | ENST00000269051.9 | c.107A>C | p.Glu36Ala | missense_variant | 1/9 | 1 | NM_138328.3 | ENSP00000269051 | P1 | |
RHBDL3 | ENST00000431505.6 | c.107A>C | p.Glu36Ala | missense_variant | 1/8 | 1 | ENSP00000394849 | |||
RHBDL3 | ENST00000538145.5 | c.107A>C | p.Glu36Ala | missense_variant | 1/8 | 1 | ENSP00000442092 | |||
RHBDL3 | ENST00000578006.5 | c.107A>C | p.Glu36Ala | missense_variant, NMD_transcript_variant | 1/9 | 1 | ENSP00000463941 |
Frequencies
GnomAD3 genomes AF: 0.000303 AC: 46AN: 151726Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000702 AC: 5AN: 71260Hom.: 0 AF XY: 0.0000488 AC XY: 2AN XY: 40960
GnomAD4 exome AF: 0.0000338 AC: 44AN: 1303012Hom.: 0 Cov.: 25 AF XY: 0.0000280 AC XY: 18AN XY: 642866
GnomAD4 genome AF: 0.000310 AC: 47AN: 151834Hom.: 0 Cov.: 32 AF XY: 0.000323 AC XY: 24AN XY: 74226
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 05, 2021 | The c.107A>C (p.E36A) alteration is located in exon 1 (coding exon 1) of the RHBDL3 gene. This alteration results from a A to C substitution at nucleotide position 107, causing the glutamic acid (E) at amino acid position 36 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at